Novartis Ag (NVS) Assets Average (2009 - 2026)

Novartis Ag has disclosed Assets Average across 18 years of filings, most recently posting $120.3 billion for Q2 2026.

• In Q2 2026, Assets Average rose 17.73% year-over-year to $120.3 billion; the TTM figure through Jun 2026 stood at $120.3 billion (up 17.73% YoY), while the FY2025 annual figure was $106.6 billion, up 5.44% from the prior year.
• Assets Average came in at $120.3 billion for Q2 2026 at Novartis Ag, up from $114.7 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $128.5 billion in Q1 2022 to a low of $95.9 billion in Q2 2024.
• Average Assets Average over 5 years is $110.3 billion, with a median of $110.4 billion recorded in 2023.
• Year-over-year, Assets Average retreated 15.42% in 2024 and advanced 17.73% in 2026.
• Over 5 years, Assets Average stood at $118.0 billion in 2022, then retreated by 9.87% to $106.3 billion in 2023, then fell by 3.23% to $102.9 billion in 2024, then increased by 6.06% to $109.1 billion in 2025, then advanced by 10.23% to $120.3 billion in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $120.3 billion in Q2 2026, $114.7 billion in Q1 2026, and $109.1 billion in Q4 2025.